LLM Token Prices collapsed by almost 60% in Q2, and will likely force a cut in AI capex. Global interest rates are soaring, which means higher costs for hyperscalers. The AI bubble burst is likely already in progress, will likely accelerate in Q3 and Q4. https://t.co/zi4WTGzHce
Xynova just unveiled Prima 1, an advanced robotic hand featuring 22 degrees of freedom.
It uses vision and tactile sensing to interact with objects more intelligently, while its direct-drive motors allow it to move rapidly and handle loads of up to 20 kg.
The progress in robotic hands is getting insane.
And here is the moment many of you were waiting for - Insilico launches series of SOTA foundation models for drug discovery. Partners can deploy individually, orchestrate via MCP, distill them or train with them in #MMAIGym
Hospitals racing ahead on AI adoption just posted the lowest mortality rates in 2026. The chart is clear, high ambient-AI systems pulled away while laggards ticked back up.
Correlation isn’t causation, but when the tool that reduces documentation burden and surfaces insights coincides with fewer deaths, the burden of proof starts shifting.
AI isn’t replacing doctors, it’s giving the good ones more time to actually practice medicine. This is the early signal we should be accelerating, not debating.
A humanoid robot can perform aerial cartwheels on uneven ground and land smoothly, thanks to a new framework called BeyondMimic.
Learn more in @SciRobotics: https://t.co/zEXO4rrPUw
Dexterous robots have a data problem that gets expensive very quickly, and recently, so many brilliant data projects are coming to resolve this problem.
X Square Robot released TwinDEX, a matched wearable-and-robotic hand system that lets humans collect robot training data without using a robot. This will potentially remove one of the biggest limits on scaling dexterous robot learning.
Claims up to 5.3X the effective collection throughput of on-robot teleoperation
TwinDEX combines a wearable three-finger data-collection hand with a closely matched robotic hand so human demonstrations can transfer directly into robot control without collecting them on the robot itself.
@aeskathon@SelectStarMan@DrSamuelBHume True of any intervention--even those vetted by medical science. Biology is complicated... statistics are general. Rapamycin can kill. People take it every day for longevity.
Roughly 10% to 20% of all recognized human diseases are directly caused by the total presence, absence, or structural alteration of a single, specific protein.
However, if you broaden the scope to include conditions where a specific protein plays a primary causal driver (even if other environmental or genetic factors are involved), the number rises to roughly 70% to 80%.
@JamesPeyer Great, but CR is hard and most won´t do it. People are breaking down doctors´ doors to get Sema. So what if it isn´t a true longevity drug. (Frankly I doubt rapamycin is either). But be that as it may, if the goal is to get people to live longer--a pure good!
Roughly 10% to 20% of all recognized human diseases are directly caused by the total presence, absence, or structural alteration of a single, specific protein.
However, if you broaden the scope to include conditions where a specific protein plays a primary causal driver (even if other environmental or genetic factors are involved), the number rises to roughly 70% to 80%.
Chemically enhanced suppressor tRNAs combined with a lung-targeted delivery system can restore production of a critical protein in models of cystic fibrosis caused by nonsense mutations, according to a new study in Science.
📄: https://t.co/XFDfZTFImB
#SciencePerspective: https://t.co/oa2gepbJU3